1 - 4 out of 4Page size: 10
  1. 2019

  2. Limited data to evaluate real-world effectiveness of enzyme replacement therapy for mucopolysaccharidosis type I

    Kuiper, G-A., Nijmeijer, S. C. M., Roelofs, M. J. M., van der Lee, J. H., Hollak, C. E. M. & Bosch, A. M., Sept 2019, In: Journal of inherited metabolic disease. 42, 5, p. 762-775

    Research output: Contribution to journal › Review article › Academic › peer-review

  3. Capturing MPS I: From early diagnosis to late complications

    Kuiper, G. A., 2019, 213 p.

    Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

  4. 2018

  5. Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications

    Kuiper, G-A., Meijer, O. L. M., Langereis, E. J. & Wijburg, F. A., 2018, In: Orphanet journal of rare diseases. 13, 1, p. 2

    Research output: Contribution to journal › Article › Academic › peer-review

  6. 2017

  7. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation

    Kuiper, G-A., van Hasselt, P. M., Boelens, J. J., Wijburg, F. A. & Langereis, E. J., 2017, In: Molecular genetics and metabolism. 122, 1-2, p. 86-91

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 68341